ENT Devices Market Size, CAGR, Trends | Report 2022-2030

According to Vision Research Reports, the global ENT Devices market size is expected to be worth around US$ 32.05 billion by 2030.

According to Vision Research Reports, the global ENT Devices market size is expected to be worth around US$ 32.05 billion by 2030.

The global ENT Devices market size was valued at US$ 27.2 billion in 2020 and is anticipated to grow at a CAGR of15.0% during forecast period 2021 to 2030.

Report Highlights

  • In 2020, the diagnostic ENT devices segment dominated the market and accounted for the largest revenue share of 28.5%.
  • North America dominated the market for ENT devices and accounted for the largest market share of 36.0% in 2020.
  • In Europe, the market accounted for the second-largest revenue share in 2020.
  • By product, the ENT devices market was valued at USD 7.7 billion in 2021 and expected to witness growth at a CAGR of 5.2% from 2022 to 2030.

Immediate Delivery Available | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/37725

Ear, nose and throat are some of the most important parts of the human body. It is very essential to keep these parts function properly. There are many factors, such as aging and sinusitis, affect the normal function of these organs. ENT, one of the most important branches of medical science, primarily focused to diagnosis and treatment of the various problems associated with ear, nose and throat.

In addition, various ENT devices are available for the diagnosis and treatment of these organs associated diseases. Some of the most common ENT devices are diagnostic devices, surgical devices and therapeutic devices. Deficiencies related to hearing, smelling and speaking are diagnose and treated by the help of these ENT devices.

ENT Devices Market Size 2020 to 2030

Growth Factors

Widening base of geriatric population worldwide is leading to increased prevalence of age-related illnesses such as hearing loss and decrease in functioning levels of ENT. This, in turn, is expected to augment the market. Rising disposable income and well-established healthcare infrastructure are also projected to work in favor of the market.

Rise in age also causes weak immunity system, which makes older people more susceptible to infections such as sore throat. According to the Action on Hearing Loss Information, one out of every six people or over 10 million people in the U.K. suffered from hearing loss. Out of these, 6.4 million people belonged to the age group of 65 and above and 800,000 people suffered from severe or profound deafness.

Hearing service offices and general healthcare service associations of local governments, in both developed and developing economies, are raising their emphasis on early screening of hearing loss and dispensing of hearing aids to its people. As the healthcare sector in emerging economies move towards privatization, the healthcare infrastructure in these regions is also developing rapidly.

Education and increased awareness about health and wellbeing among the general population is also playing a critical role in spurring the demand for and diagnostic services globally. Subsidies, grants, and funding are offered by several governments across the world to prevent and manage ENT disorders. These factors are poised to stoke the growth of the market over the forecast period.

Spiraling adoption rates of ENT devices, impairments due to usage of aesthetic products, increasing awareness among patients and healthcare professionals, and rising trend for nasal correction procedures are anticipated to trigger the growth of the market. Growing adoption of user-friendly material in manufacturing of these devices are also likely to benefit the market.

Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/37725

Report Coverage

Report Scope

Details

Market Size

USD 32.05 billion by 2030

Growth Rate

CAGR of15.0% From 2021 to 2030

Base Year

2020

Historic Data

2017 to 2020

Forecast Period

2021 to 2030

Segments Covered

Product

Regional Scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Companies Mentioned

Demant A/S; Sonova; Ambu A/S; Pentax Medical; Karl Storz; Olympus Corporation; Richard Wolf Gmbh; Widex; Cochlear Ltd.; Sivantos, Inc.; Starkey Hearing Technologies; Gn Resound A/S; Rion Co., Ltd.; Welch Allyn; Atos Medical Ab

Global ENT Devices Market Challenges

The factors restraining the growth of the global ENT devices market include the high cost of the ENT procedures and the social stigma associated with hearing disorders. The high cost has limited the procedure volume in emerging as well as developed economies. For instance, according to a study published in NCBI in 2018, titled, ‘Health Care Costs and Cost-Effectiveness in Laryngotracheal Stenosis’, treatment of laryngotracheal stenosis (LTS) is one of the expensive ENT procedures. The mean annual cost associated with the disease was $4,080.09. Furthermore, according to another study titled, ‘Comparison of the Financial Burden of Survivors of Head and Neck Cancer with Other Cancer Survivors’, which was published in March 2019, patients getting treatment for head and neck cancer bear higher expenses as compared to other cancer patients. Also, these patients bear higher out-of-pocket costs. Thus, the high cost of the procedures and lack of reimbursement harm the growth of the global ENT devices market.

Global ENT Devices Market Opportunities

Emerging of regional ENT devices manufacturers and synergies between local healthcare authorities and key medical device companies are the major opportunities in the global ENT devices market. The key companies operating in the market can expand in emerging economies by partnering with local healthcare authorities. Such synergies will enable the companies to penetrate the markets effectively and expand their customer base. For instance, Cochlear Limited partnered with The Royal Victorian Eye and Ear Hospital in the U.K. for the development of Geelong Cochlear Care Centre. The center is the first care center of Cochlear Limited in the U.K. and is projected to improve the company’s presence in the country.

Impact of COVID-19 on the Global ENT Devices Market

During COVID-19, the growth of the ENT devices market was negatively impacted, especially in 2020. Although the ENT facilities continued to operate, the sales of the companies were negatively impacted. Nonetheless, the market grew minimally in 2020 and is projected to witness considerable growth during the forecast period 2021-2030. The increasing technological innovations in the global market and growing adoption in emerging economies are the factors for the growth of the market.

Product Insights

In 2020, the diagnostic ENT devices segment dominated the market and accounted for the largest revenue share of 28.5%. This growth is due to the availability of several products and the presence of major market players. Some of the key players in the market offering diagnostic ENT devices are Hill-Rom.; Karl Storz GmbH & Co KG; MAICO Diagnostics GmbH; BioMed Jena GmbH; PATH medical GmbH; Fujifilm Corporation; Ambu A/S Smith; Nephew PLC.; iHEARmedical, Inc.; Veran Medical Technologies; and HederaBiomedicsS.r.l.

New product launches and mergers and acquisitions are prominent growth strategies adopted by these players. For instance, in July 2017, PENTAX Medical-a HOYA Group division and Shanghai AohuaPhotoelectricity Endoscope Co., Ltd. announced a joint venture to create products in the field of flexible medical endoscopy.

However, the hearing aids segment is likely to grow at the fastest rate during the forecast period. This can be attributed to the entry of various players, increasing adoption of these devices, and technological advancements due to an increase in investment by market players on R&D. For instance, in February 2020, Starkey Hearing Technologies announced the launch of Livio Edge AI. It combines the best of both technologies-sound processing and sound quality-for challenging listening environments.

Regional Insights

North America dominated the market for ENT devices and accounted for the largest market share of 36.0% in 2020. This can be attributed to the high prevalence of ENT-related disorders in the region; increased demand for hearing care devices; and presence of large hospitals chains, highly equipped ambulatory facilities, and a significant target population. In addition, the local presence of key market players, supportive government regulations for portable medical devices, and high adoption of advanced technology are also key factors for the dominance in the market.

In Europe, the market accounted for the second-largest revenue share in 2020. The region has high product penetration for hearing aids due to well-established healthcare infrastructure and high patient awareness levels. Asia Pacific is anticipated to grow at the fastest rate during the forecast period due to increasing awareness about early diagnosis of diseases, growing healthcare expenditure, and rising investment by market players. Olympus Corporation, a Japan-based company, in May 2018, introduced ENF-VT3, a rhino-laryngovideoscope, to integrate 4-direction angulation capability.

Singapore, Thailand, Australia, and South Korea are some of the emerging countries in the Asia Pacific region. Technological advancements, such as wireless, real-time monitoring, increase in healthcare spending in the Asia Pacific region, and support from regulatory bodies are anticipated to promote the growth of the ENT devices market.

Key Players

Siemens Healthcare; Widex A/S; Atos Medical AB; Starkey Laboratories Inc.; GN ReSound A/S; William Demant Holding A/S; Sonova Holding AG; Cochlear Limited; Rion Co.; Ltd.; and Welch Allyn.

Market Segmentation

  • Product Outlook
    • Diagnostic Ear, Nose, And Throat (ENT) Devices
      • Rigid Endoscopes
        • Rhinoscopes
        • Laryngoscopes
        • Otological Endoscopes
      • Flexible Endoscopes
      • Robot Assisted Endoscope
      • Hearing Screening Device
    • Surgical Ear, Nose, And Throat (ENT) Devices
      • Radiofrequency Handpieces
      • Powered Surgical Instrument
      • Otological Drill Burrs
      • ENT Hand Instruments
      • Tympanostomy Tubes
      • Sinus Dilation Devices
      • Nasal Packing Devices
    • Hearing Aids Ear, Nose, And Throat (ENT) Devices
      • Behind-the-Ear (BTE) aids
      • In-the-Ear aids
      • Receiver-in-the-Ear (RITE)
      • Canal hearing aids ITC, CIC and IIC
    • Hearing Implants Ear, Nose, And Throat (ENT) Devices
      • Auditory Brainstem Implants
      • Cochlear Implants
      • Middle Ear Implants
      • Bone Anchored Hearing System
    • Nasal Splints Ear, Nose, And Throat (ENT) Devices
      • Internal Nasal Splints
      • External Nasal Splints
  • Regional Outlook
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Click Here to View Full Report Table of Contents

Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/37725

You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333